证券代码：600881 证券简称：亚泰集团 公告编号：临 2025-089 号 吉林亚泰（集团）股份有限公司 关于为所属子公司提供担保的公告 一、担保情况概述 （一）担保的基本情况 1、同意公司及吉林亚泰鼎鹿水泥有限公司继续为吉林亚泰超市有限公司在 长春农村商业银行股份有限公司会展中心支行申请的流动资金借款 4,950 万元提 供连带责任保证，并以吉林亚泰鼎鹿水泥有限公司名下位于长春市四通路的厂区 土地及地上建筑物提供抵押担保。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 | | 被担保人名称 | 吉林亚泰超市有限公司 | | --- | --- | --- | | | 本次担保金额 | 4,950 万元 | | 担保对象一 | 实际为其提供的担保余额 | 万元 42,700 | | | 是否在前期预计额度内 | □是 □否 不适用：无前期预计额 度 | | | 本次担保是否有反担保 | □是 否 □不适用：_________ | | 担保对象二 | 被担保人名称 | 亚泰集团长春建 ...

证券代码：600881 证券简称：亚泰集团 公告编号：临 2025-091 号 吉林亚泰（集团）股份有限公司 关于筹划重大资产出售暨关联交易的进展公告 特 别 提 示 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 一、本次交易概述 公司本次出售已经构成《上市公司重大资产重组管理办法》规定 的重大资产重组。 公司于 2024 年 3 月 28 日披露了《吉林亚泰（集团）股份有限公 司关于筹划重大资产出售暨关联交易的提示性公告》（公告编号：临 2024-016 号），对本次交易涉及的相关事项进行了详细说明。 公司分别于 2024 年 5 月 9 日、6 月 8 日、7 月 9 日、8 月 9 日、 9 月 10 日、9 月 28 日、10 月 30 日、11 月 30 日、12 月 31 日和 2025 1 年 1 月 28 日、2 月 28 日、3 月 29 日、4 月 29 日、5 月 30 日、6 月 28 日、7 月 30 日披露了《吉林亚泰（集团）股份有限公司关于筹划 重大资产出售暨关联交易的进展公告》（公告编号：临 ...

证券代码：600881 证券简称：亚泰集团 公告编号：临 2025-090 号 吉林亚泰(集团)股份有限公司 关于召开2025年第八次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 吉林亚泰（集团）股份有限公司（以下简称"公司"）于 2025 年 8 月 27 日召 开的第十三届第八次董事会审议通过了《关于召开 2025 年第八次临时股东大会 的有关事宜》，同意于 2025 年 9 月 16 日召开 2025 年第八次临时股东大会，具 体如下： 一、 召开会议的基本情况 (一)股东大会类型和届次 2025年第八次临时股东大会 (二)股东大会召集人：董事会 (三)投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结合的 方式 股东大会召开日期：2025年9月16日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 9 月 16 日 15 点 00 分 召开地点：亚泰会议中心会议室 (五)网络投票的 ...

证券代码：600881 证券简称：亚泰集团 公告编号：临 2025-088 号 吉林亚泰（集团）股份有限公司 第十三届第八次监事会决议公告 特 别 提 示 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 吉林亚泰（集团）股份有限公司（以下简称"公司"）第十三届第 八次监事会会议于 2025 年 8 月 27 日在亚泰会议中心会议室举行，监 事会主席曲国辉先生主持了会议，会议应出席监事 7 名，实际出席监 事 7 名，会议符合法律、法规、规章和《公司章程》的有关规定，会 议审议并一致通过了公司 2025 年半年度报告及其摘要。 监事会认为，公司 2025 年半年度报告编制和审议程序符合法律、 法规、公司章程和公司各项管理制度的规定；公司 2025 年半年度报 告的内容和格式符合中国证监会和上海证券交易所的各项规定，所包 含的信息能够真实、准确、完整地反映公司 2025 年上半年的经营管 理和财务状况等事项；未发现参与 2025 年半年度报告编制和审议的 人员有违反保密规定的行为。 表决结果：同意 7 票，反对 0 票，弃权 0 ...

表决结果：同意 13 票，反对 0 票，弃权 0 票。 二、审议通过了关于公司申请融资的议案。 鉴于公司部分综合授信即将到期，同意公司在吉林银行股份有 限公司申请综合授信 3 亿元，期限 1 年，并由吉林大药房药业股份 有限公司提供连带责任保证。 证券代码：600881 证券简称：亚泰集团 公告编号：临 2025-087 号 吉林亚泰（集团）股份有限公司 第十三届第八次董事会决议公告 特 别 提 示 本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完 整性承担法律责任。 吉林亚泰（集团）股份有限公司（以下简称"公司"）第十三届 第八次董事会会议于 2025 年 8 月 27 日在亚泰会议中心会议室举 行，董事长陈铁志先生主持了会议，会议应出席董事 13 名，实际出 席董事 11 名，董事韩冬阳先生、独立董事邴正先生分别委托董事秦 音女士、独立董事杜婕女士代为出席并行使表决权，会议符合法 律、法规、规章和《公司章程》的有关规定，会议审议并一致通过 了以下议案： 一、审议通过了公司 2025 年半年度报告及其摘要。 公司 2025 年半年度报告及其摘要 ...

Financial Performance - The company's operating revenue for the first half of 2025 was CNY 3,036,573,704.27, representing a 3.67% increase compared to CNY 2,928,976,640.74 in the same period last year[18]. - The total profit for the first half of 2025 was a loss of CNY 992,078,551.05, an improvement of 13.22% from a loss of CNY 1,143,154,112.82 in the previous year[18]. - The net profit attributable to shareholders for the first half of 2025 was a loss of CNY 822,889,469.89, which is 11.27% better than the loss of CNY 927,396,454.07 in the same period last year[18]. - The basic earnings per share for the first half of 2025 was CNY -0.25, an improvement of 13.79% from CNY -0.29 in the same period last year[19]. - The net loss for the first half of 2025 was CNY 1,003,900,009.03, compared to a net loss of CNY 1,147,200,570.61 in the same period of 2024, showing an improvement of about 12.5%[109]. - The company reported a gross profit margin of approximately 46.0% for the first half of 2025, compared to 26.0% in the previous year, reflecting a significant increase in profitability[108]. - The company's financial expenses for the first half of 2025 were CNY 948,101,631.54, down from CNY 1,001,588,864.67, representing a decrease of approximately 5.3%[108]. Cash Flow and Assets - The net cash flow from operating activities was CNY -688,599.04, a significant decline from CNY 206,247,006.42 in the previous year, marking a 100.33% decrease[18]. - The total assets as of the end of the reporting period were CNY 42,200,420,429.02, showing a slight decrease of 0.09% from CNY 42,239,691,474.42 at the end of the previous year[18]. - The total liabilities amounted to CNY 39,924,570,050.31, up from CNY 38,876,726,266.20, showing an increase of 2.7%[103]. - The total current assets of Jilin Yatai (Group) Co., Ltd. as of June 30, 2025, amounted to RMB 19,179,578,923.95, an increase from RMB 18,894,279,667.76 as of December 31, 2024[101]. - The cash and cash equivalents held by the company reached RMB 843,217,527.46 as of June 30, 2025, compared to RMB 739,467,052.78 at the end of 2024[101]. Investments and Shareholding - The company holds a 30.81% stake in Northeast Securities and a 6.88% stake in Jilin Bank, making it the largest shareholder of Northeast Securities and a major shareholder of Jilin Bank[21]. - The company plans to sell 20.81% of its shares in Northeast Securities to Changchun Urban Development Investment Holding Group Co., Ltd. and 9% to Changchun Financial Holding Group Co., Ltd., with the transaction currently in the planning stage[46]. - The company reported a significant investment in Northeast Securities, with total assets of 9,964,731.14 CNY and a net profit contribution of 45,053.27 million CNY[47]. - The largest shareholder, Changchun Municipal Government, holds 295,088,616 shares, representing 9.13% of total shares[93]. Operational Strategies - The company aims to stabilize core customers and explore incremental markets through strategic collaborations on urban renewal and infrastructure projects[25]. - The company is actively developing new products such as marine cement and special cements, extending the downstream industrial chain[25]. - The company is implementing measures to optimize real estate development and reduce inventory and costs[25]. - The company is focusing on risk management in its pharmaceutical research and development efforts, addressing the high costs and uncertainties associated with new drug development[52]. Governance and Compliance - The company has organized 6 shareholder meetings and 9 board meetings in the first half of 2025, ensuring effective governance and decision-making[57]. - The company is committed to enhancing investor communication, having completed 2 regular reports and 70 temporary announcements in the first half of 2025[59]. - The company has no significant litigation or arbitration matters during the reporting period, indicating a stable legal standing[74]. - The company has committed to fair and transparent transactions with related parties, minimizing potential conflicts of interest[70]. Research and Development - Research and development expenses rose by 20.19% to ¥57,120,543.55, up from ¥47,525,241.41 in the previous year[32]. - The pharmaceutical sector is expected to continue growing due to increasing demand for high-quality medicines driven by economic development and an aging population[24]. - The pharmaceutical segment has seen a nearly 20% year-on-year increase in sales volume for Vitamin D2 due to sales model adjustments[55]. - The company has launched 23 new patents and 2 software copyrights in the first half of 2025, bringing the total to over 500 patents and nearly 160 software copyrights[56]. Financial Management - The company has completed 11 cash dividend distributions since its listing, totaling CNY 1.384 billion, and has repurchased 20,664,800 shares for a total expenditure of CNY 30.98 million[58]. - The company is actively pursuing a strategy to enhance operational efficiency and reduce debt, focusing on optimizing asset structure and improving cash flow management[53]. - The company has implemented a special action plan aimed at improving operational quality and enhancing investor confidence, with a focus on stabilizing operations and fostering development[53]. - The company has committed to not reducing its shareholdings for 12 months starting from July 1, 2024, ensuring stability in its equity structure[75].

2024年3月27日，吉林亚泰（集团）股份有限公司拟将持有的东北证券20.81%股份售予长发集团，9%股 份售予长春市金控或其指定下属子公司，此交易构成重大资产重组。公司自2024年3月28日起多次披露 进展。截至8月29日公告披露日，公司就该重大资产出售与各相关方持续沟通协商，积极推进尽职调查 等工作。不过，本次交易尚处筹划阶段，具体方案待论证协商，需履行必要决策和审批程序，相关事项 存在不确定性。公司将依规履行信息披露义务，提醒投资者注意风险。 ...

Market Overview - On August 28, the comprehensive sector rose by 0.92% compared to the previous trading day, with Dongyangguang leading the gains [1] - The Shanghai Composite Index closed at 3843.6, up 1.14%, while the Shenzhen Component Index closed at 12571.37, up 2.25% [1] Stock Performance - Dongyangguang (600673) closed at 20.43, with a gain of 2.61% and a trading volume of 791,200 shares, amounting to a transaction value of 1.59 billion [1] - Yatai Group (600881) closed at 2.07, up 1.47%, with a trading volume of 1,560,300 shares and a transaction value of 320 million [1] - Zongyi Co. (600770) closed at 6.26, up 1.46%, with a trading volume of 833,300 shares and a transaction value of 520 million [1] - Other notable stocks include Te Li A (000025) at 17.64 (+0.40%), and Hongmian Co. (000523) at 3.29 (+0.30%) [1] Capital Flow - The comprehensive sector experienced a net outflow of 364 million from institutional funds, while retail funds saw a net inflow of 209 million [2] - The net inflow from speculative funds was 155 million [2] Individual Stock Capital Flow - Yatai Group saw a net inflow of 24.71 million from institutional funds, while it experienced a net outflow of 22.78 million from speculative funds [3] - Hongmian Co. had a net inflow of 2.50 million from institutional funds and a net inflow of 3.64 million from speculative funds [3] - Shanghai Sanmao (600689) experienced a net outflow of 4.56 million from institutional funds, but a net inflow of 1.68 million from retail investors [3]

Market Overview - The Shanghai Composite Index fell by 1.76% on August 27, with only one industry, telecommunications, showing an increase of 1.66% [1] - The sectors with the largest declines were beauty care and real estate, down 3.86% and 3.51% respectively [1] Capital Flow - There was a net outflow of 129.75 billion yuan from the main funds in the two markets, with all sectors under Shenwan experiencing net outflows [1] - The computer industry had the largest net outflow, totaling 16.31 billion yuan, followed by the pharmaceutical and biological sector with a net outflow of 12.32 billion yuan [1] Comprehensive Industry Performance - The comprehensive industry dropped by 3.14%, with a net outflow of 428 million yuan, and 15 out of 16 stocks in this sector declined [1] - The top three stocks with the largest net outflows included Dongyangguang, Yuegui, and Nanjing Xinbai, with outflows of 144.91 million yuan, 73.73 million yuan, and 53.51 million yuan respectively [1] Stock Performance - The stock performance table indicates that Dongyangguang had a decline of 3.21% with a turnover rate of 2.68% and a net outflow of 144.91 million yuan [1] - Tianchen Co. was the only stock in the comprehensive industry to maintain a stable price, with a net inflow of 17.58 million yuan [1]

Core Viewpoint - Yatai Group has signed a strategic cooperation agreement with China Construction Infrastructure Co., Ltd. to enhance collaboration in various sectors including product supply, infrastructure construction, and new energy [1] Group 1: Strategic Cooperation - The agreement emphasizes long-term, mutually beneficial, win-win cooperation and joint development [1] - The collaboration will involve complementary qualifications, forming joint ventures, and establishing partnerships [1] Group 2: Areas of Collaboration - The partnership will focus on comprehensive and in-depth business cooperation in product supply and services, infrastructure construction, new energy, and supply chain [1] - The initial focus will be on expanding from Changchun City to surrounding provinces and cities [1]